The vitamin D status and the levels of β1- and β2-defensins in children and adolescents with different forms of pulmonary TB
https://doi.org/10.21518/ms2024-006
Abstract
Introduction. The basic research demonstrated an important role of vitamin D in strengthening the immune response to Mycobacterium tuberculosis and proved its effect on the production of antimicrobial peptides. However, the correlation between the levels of vitamin D and defensins (β1 and β2) in children and adolescents with different forms of pulmonary TB was not studied.
Aim. To study the correlation between the levels of vitamin D and β1- and β2-defensins in children and adolescents with different forms of pulmonary TB.
Materials and methods. We carried out a prospective study of 75 patients with pulmonary TB aged 2–17 years (52 new cases and 23 retreatment cases) in 2021–2023. The levels of 25(OH)D and β1- and β2-defensins were determined at admission to hospital.
Results. Out of 75 patients 2.7% had adequate levels of vitamin D (more than 30 ng/mL), 13.3% had insufficient levels of vitamin D (20 to 30 ng/mL), 34.7% had deficient levels of vitamin D (10 to 20 ng/mL), and 49.3% had severe deficiency of vitamin D (less than 10 ng/mL). We established a direct correlation between 25(OH)D and β1-defensin levels (p = 0.004766) and lack of correlation between 25(OH)D and β2-defensin levels. We discovered significant differences in the levels of 25(ОН)D and β1-defensin between new and retreatment cases: 13.10 ± 1.04 ng/mL and 8.74 ± 1.07 ng/mL (p = 0.004644) and 6.66 ± 0.79 ng/mL and 4.0 ± 0.85 ng/mL (p = 0.024816), respectively.
Conclusion. The differences in the levels of calcidiol and β1-defensin between new and retreatment cases witness an impaired function of one of the innate non-specific immunity components during long-lasting advanced pulmonary TB in children and adolescents.
About the Authors
L. V. PanovaRussian Federation
Lyudmila V. Panova, Dr. Sci. (Med.), Leading Researcher of the Child and Adolescent Department
2, Yauskaya Alley, Moscow, 107564
M. M. Averbakh
Russian Federation
Mikhail M. Averbakh, Dr. Sci. (Med.), Professor, Principal Researcher of Immunology Department
2, Yauskaya Alley, Moscow, 107564
E. S. Ovsуankina
Russian Federation
Elena S. Ovsуankina, Dr. Sci. (Med.), Professor, Principle Scientist, Head of Children and Adolescents Department
2, Yauskaya Alley, Moscow, 107564
I. N. Zakharova
Russian Federation
Irina N. Zakharova, Dr. Sci. (Med.), Professor, Honoured Doctor of the Russian Federation, Head of the Department of Pediatrics named after Academician G.N. Speransky
2/1, Bldg. 1, Barrikadnaya St., Moscow, 125993
A. V. Karasev
Russian Federation
Alexander V. Karasev, General Director
20, Bldg. 3, Nauchny Proezd, Moscow, 117246
Yu. Yu. Khokhlova
Russian Federation
Yulia Yu. Khokhlova, Cand. Sci. (Med.), Doctor of the Children’s Department of the Child and Adolescent Department
2, Yauskaya Alley, Moscow, 107564
S. S. Sterlikova
Russian Federation
Svetlana S. Sterlikova, Doctor of the Children’s Department of the Child and Adolescent Department
2, Yauskaya Alley, Moscow, 107564
References
1. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113–119. https://doi.org/10.1093/ije/dym247.
2. Buonsenso D, Pata D, Turriziani Colonna A, Ferrari V, Salerno G, Valentini P. Vitamin D and tuberculosis in children: a role in the prevention or treatment of the disease? Monaldi Arch Chest Dis. 2022;92(4). https://doi.org/10.4081/monaldi.2022.2112.
3. Papagni R, Pellegrino C, Di Gennaro F, Patti G, Ricciardi A, Novara R et al. Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients. Int J Mol Sci. 2022;23(7):3860. https://doi.org/10.3390/ijms23073860.
4. Shah I, Shetty NS, Chigari P, Pradhan V, Chougule D, Poojari VS et al. Vitamin D receptor genetic polymorphisms in severe and recurrent tuberculosis in children. Indian J Tuberc. 2023;70(2):239–244. https://doi.org/10.1016/j.ijtb.2022.05.011.
5. Ganz T. Defensins: antimicrobial peptides of vertebrates. C R Biol. 2004;327(6):539–549. https://doi.org/10.1016/j.crvi.2003.12.007.
6. Zaharova IN, Klimov LYa, Kasyanova AN, Kurʹyaninova VA, Dolbnya SV, Ivanova AV et al. Modern conception about vitamin D immunotropic effects. Clinical Practice in Pediatrics. 2019;14(1):7–17. (In Russ.) https://doi.org/10.20953/1817-7646-2019-1-7-17.
7. Yegorov S, Bromage S, Boldbaatar N, Ganmaa D. Effects of vitamin D supplementation and seasonality on circulating cytokines in adolescents: Analysis of data from a feasibility trial in Mongolia. Front Nutr. 2019;6:166. https://doi.org/10.3389/fnut.2019.00166.
8. Wu HX, Xiong X, Zhu M, Wei J, Zhuo K, Cheng D. Effects of vitamin D supplementation on the outcomes of patients with pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med. 2018;18(1):108. https://doi.org/10.1186/s12890-018-0677-6.
9. Wang J, Feng M, Ying S, Zhou J, Li X. Efficacy and Safety of Vitamin D Supplementation for Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Iran J Public Health. 2018;47:466–472. Available at: https://pubmed.ncbi.nlm.nih.gov/29900130.
10. Neme A, Nurminen V, Seuter S, Carlberg C. The vitamin D-dependent transcriptome of human monocytes. J Steroid Biochem Mol Biol. 2016;164:180–187. https://doi.org/10.1016/j.jsbmb.2015.10.018.
11. Verway M, Bouttier M, Wang TT, Carrier M, Calderon M, An BS et al. Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog. 2013;9(6):e1003407. https://doi.org/10.1371/journal.ppat.1003407.
12. Moideen K, Nathella PK, Madabushi S, Renji RM, Srinivasan P, Ahamed SF et al. Plasma Vitamin D levels in correlation with circulatory proteins could be a potential biomarker tool for pulmonary tuberculosis and treatment monitoring. Cytokine. 2023;168:156238. https://doi.org/10.1016/j.cyto.2023.156238.
13. Petrushina AD, Slashcheva DM, Brynza NS, Pirogova ND, Sosnovskaya SV, Chernova AP. Vitamin D and latent tuberculosis infection in schoolchildren. Russian Pediatric Journal. 2019;22(6):344–348. (In Russ.) Available at: https://cyberleninka.ru/article/n/vliyanie-vitamina-d-na-techenie-latentnoytuberkuleznoy-infektsii-u-detey-shkolnogo-vozrasta/viewer.
14. Middelkoop K, Stewart J, Walker N, Delport C, Jolliffe DA, Coussens AK et al. Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids). Int J Infect Dis. 2023;134:63–70. https://doi.org/10.1016/j.ijid.2023.05.010.
15. Gou X, Pan L, Tang F, Gao H, Xiao D. The association between vitamin D status and tuberculosis in children: A meta-analysis. Medicine (Baltimore). 2018;97(35):e12179. https://doi.org/10.1097/MD.0000000000012179.
16. Tamara L, Kartasasmita CB, Alam A, Gurnida DA. Effects of Vitamin D supplementation on resolution of fever and cough in children with pulmonary tuberculosis: A randomized double-blind controlled trial in Indonesia. J Glob Health. 2022;12:04015. https://doi.org/10.7189/jogh.12.04015.
17. Jaimni V, Shasty BA, Madhyastha SP, Shetty GV, Acharya RV, Bekur R, Doddamani A. Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis. Pulm Med. 2021;2021:5285841. https://doi.org/10.1155/2021/5285841.
18. Zeng J, Wu G, Yang W, Gu X, Liang W, Yao Y, Song Y. A serum vitamin D level <25nmol/l pose high tuberculosis risk: a meta-analysis. PLoS ONE. 2015;10(5):e0126014. https://doi.org/10.1371/journal.pone.0126014.
19. Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020;12(7):2097. https://doi.org/10.3390/nu12072097.
20. Zaharova IN, Cucaeva AN, Klimov LYa, Kur’yaninova V.A, Dolbnya S.V, Zaplatnikov AL et al. Vitamin D and defensins production in infants. Meditsinskiy Sovet. 2020;(1):158–169. (In Russ.) https://doi.org/10.21518/2079-701X-2020-1-158-169.
Review
For citations:
Panova LV, Averbakh MM, Ovsуankina ES, Zakharova IN, Karasev AV, Khokhlova YY, Sterlikova SS. The vitamin D status and the levels of β1- and β2-defensins in children and adolescents with different forms of pulmonary TB. Meditsinskiy sovet = Medical Council. 2024;(1):90–96. (In Russ.) https://doi.org/10.21518/ms2024-006